{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:38:04Z","timestamp":1793284684747,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"am","delay-in-days":399,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.biologicals.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T08:47:59Z","timestamp":1596703679000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Processing bovine intestinal mucosa to active heparin removes spiked BSE agent"],"prefix":"10.1016","volume":"67","author":[{"given":"Omozusi","family":"Andrews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Bett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kaelber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Asher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Keire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2020.06.004_bib1","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1021\/jm030176m","article-title":"Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity","volume":"46","author":"Linhardt","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.biologicals.2020.06.004_bib2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nbt1407","article-title":"Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events","volume":"26","author":"Guerrini","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biologicals.2020.06.004_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1039\/b819896a","article-title":"Lessons learned from the contamination of heparin","volume":"26","author":"Liu","year":"2009","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.biologicals.2020.06.004_bib4","author":"Food and Drug Administration"},{"issue":"9","key":"10.1016\/j.biologicals.2020.06.004_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/v11090864","article-title":"An update on african swine fever virology","volume":"11","author":"Karger","year":"2019","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.biologicals.2020.06.004_bib6","article-title":"Diversifying the global heparin supply chain: reintroduction of Bovine Heparin in the United States?","volume":"39","author":"Keire","year":"2015","journal-title":"Pharmaceut Technol"},{"key":"10.1016\/j.biologicals.2020.06.004_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.biologicals.2020.06.004_bib8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","article-title":"The same prion strain causes vCJD and BSE","volume":"389","author":"Hill","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2020.06.004_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmissions to mice indicate that \u2018new variant\u2019 CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2020.06.004_bib11","author":"Food and Drug Administration"},{"key":"10.1016\/j.biologicals.2020.06.004_bib12","author":"Food and Drug Administration"},{"key":"10.1016\/j.biologicals.2020.06.004_bib13","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1208\/s12248-017-0047-y","article-title":"A heparin purification process removes spiked transmissible spongiform encephalopathy agent","volume":"19","author":"Bett","year":"2017","journal-title":"AAPS"},{"key":"10.1016\/j.biologicals.2020.06.004_bib14","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1021\/acs.jmedchem.7b01269","article-title":"Enzymatic generation of highly anticoagulant bovine intestinal heparin","volume":"60","author":"Fu","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.biologicals.2020.06.004_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4161\/pri.5.3.16893","article-title":"Real-time quaking-induced conversion: a highly sensitive assay for prion detection","volume":"5","author":"Atarashi","year":"2011","journal-title":"Prion"},{"issue":"12","key":"10.1016\/j.biologicals.2020.06.004_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225904","article-title":"Quaking-induced conversion of prion protein on a thermal mixer accelerates detection in brains infected with transmissible spongiform encephalopathy agents","volume":"14","author":"Kaelber","year":"2019","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.biologicals.2020.06.004_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001217","article-title":"Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays","volume":"6","author":"Wilham","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biologicals.2020.06.004_bib18","author":"Williams"},{"issue":"6","key":"10.1016\/j.biologicals.2020.06.004_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22061025","article-title":"From farm to pharma: an overview of industrial heparin manufacturing methods","volume":"22","author":"van der Meer","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.biologicals.2020.06.004_bib20","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1002\/jps.21729","article-title":"Analysis of pharmaceutical heparins and potential contaminants using 1H-NMR and PAGE","volume":"98","author":"Zhang","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.biologicals.2020.06.004_bib21","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1086\/379664","article-title":"Enzymatic degradation of prion protein in brain stem from infected cattle and sheep","volume":"188","author":"Langeveld","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2020.06.004_bib22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1076029616643822","article-title":"Analysis of heparins derived from bovine tissues and comparison to porcine intestinal heparins","volume":"22","author":"St Ange","year":"2016","journal-title":"J Clin Appl Thromb Hemost"},{"key":"10.1016\/j.biologicals.2020.06.004_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1297-9716-42-21","article-title":"BSE infectivity in jejunum, ileum and ileocaecal junction of incubating cattle","volume":"42","author":"Hoffmann","year":"2011","journal-title":"Vet Res"},{"key":"10.1016\/j.biologicals.2020.06.004_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcpa.2011.01.010","article-title":"Experimental bovine spongiform encephalopathy: detection of PrP(Sc) in the small intestine relative to exposure dose and age","volume":"145","author":"Stack","year":"2011","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.biologicals.2020.06.004_bib25","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/trf.12050","article-title":"Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies","volume":"53","author":"Cai","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.biologicals.2020.06.004_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/B978-0-444-63945-5.00007-6","article-title":"Atypical and classic bovine spongiform encephalopathy","volume":"153","author":"Casalone","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.biologicals.2020.06.004_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1297-9716-42-21","article-title":"BSE infectivity in jejunum, ileum and ileocaecal junction of incubating cattle","volume":"42","author":"Hoffmann","year":"2011","journal-title":"Vet Res"},{"key":"10.1016\/j.biologicals.2020.06.004_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pds.4982","article-title":"Assessment of risk of variant creutzfeldt-Jakob disease (vCJD) from use of bovine heparin","volume":"29","author":"Huang","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105620300658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:14:35Z","timestamp":1760922875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105620300658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":27,"alternative-id":["S1045105620300658"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.06.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Processing bovine intestinal mucosa to active heparin removes spiked BSE agent","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of International Alliance for Biological Standardization.","name":"copyright","label":"Copyright"}]}}